ADVERTISEMENT

Body-wide, pruritic, papular rash • scalp lesion • excoriation • Dx?

The Journal of Family Practice. 2018 July;67(7):429-430
Author and Disclosure Information

► Body-wide, pruritic, papular rash
► Scalp lesion
► Excoriation

Atopic dermatitis is characterized by symmetric involvement of the flexural sur­faces of the body with a pruritic, erythematous rash that may have a fine scale.3 It usually manifests prior to 2 years of age, is recurrent, and is commonly associated with allergic rhinitis and asthma.3 Treatment involves trigger avoidance, topical emollients, topical corticosteroids, dilute bleach baths, and topical calcineurin inhibitors.3,4 For patients with significant nocturnal symptoms and sleep loss, oral antihistamines may be helpful.4

Morbilliform drug eruptions are the most common type of dermatologic drug reaction.5 These rashes occur approximately one to 2 weeks after exposure to a causative drug; they consist of pruritic, erythematous papules or macules that start centrally and may spread to the proximal extremities.5 Treatment involves discontinuation of the offending agent. Symptomatic relief may be achieved with oral antihistamines or topical or systemic corticosteroids.5

Treatment of dermatophytid reactions

While the initial impulse in the treatment of a dermatophytid reaction may be to discon­tinue oral antifungals, these treatments actually help resolve the underlying dermatophyte infection and should be continued. For children with tinea capitis, at least 6 weeks of treatment with an oral antifungal agent is warranted. Medications approved by the US Food and Drug Administration include terbinafine (for patients >4 years of age) and griseofulvin (for patients >2 years of age). Dosages are weight-based. (Fluconazole and itraconazole are not approved for this indication.) Lubricants, topical corticosteroids, and oral antihistamines can be used for acute management of pruritus.1

Our patient was treated successfully with griseofulvin and an oral antihistamine. However, he experienced headaches attrib­uted to griseofulvin and was switched to terbinafine 5 mg/kg/d for 4 weeks. His tinea capitis was resolved at 8 weeks.

CORRESPONDENCE
Richard Temple, MD, CAPT, MC, USN. Department of Family Medicine, Naval Medical Center Camp Lejeune, 100 Brewster Blvd, Camp Lejeune, NC 28547; Richard.w.temple2.mil@mail.mil.